Lipoplex and peptide-based strategies for the delivery of steric-block oligonucleotides

International Journal of Pharmaceutics

Volumn 344, Issue 1-2, 2007, Pages 96-102

  Resina, Sarah ^a   Abes, Saïd ^a   Turner, John J ^b   Prevot, Paul ^a   Travo, Adrian ^a   Clair, Philippe ^a   Gait, Michael J ^b   Thierry, Alain R ^a   Lebleu, Bernard ^a  

^a UNIVERSITÉ DE MONTPELLIER   (France)

^b MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

Author keywords

Antisense oligonucleotide; Cell penetrating peptide; Lipoplex; Splice correction

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; CELL PENETRATING PEPTIDE; CHLOROQUINE; COMPLEMENTARY RNA; DIOCTADECYLAMIDOGLYCYLSPERMIDINE; DIOLEOYLPHOSPHATIDYLETHANOLAMINE; DNA; LIPOPLEX; LIPOSOME; MESSENGER RNA; MORPHOLINE DERIVATIVE; OLIGONUCLEOTIDE; PENETRATIN; PEPTIDE DERIVATIVE; PEPTIDE NUCLEIC ACID; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CELL CULTURE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; ENDOSOME; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RNA SPLICING;

DRUG DELIVERY SYSTEMS; GENES, REPORTER; GLOBINS; HELA CELLS; HUMANS; INTRONS; LIPOSOMES; LUCIFERASES; OLIGONUCLEOTIDES, ANTISENSE; OLIGOPEPTIDES; PEPTIDE NUCLEIC ACIDS; RNA SPLICING; TRANSFECTION;

EID: 34648843316     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2007.04.039     Document Type: Article

References (33)

1. Abes S., Williams D., Prevot P., Thierry A.R., Gait M.J., and Lebleu B. Endosome trapping limits the efficiency of splicing correction by PNA-oligolysine conjugates. J. Control. Release 110 (2006) 595-604
2. Abes S., Moulton H.M., Clair P., Prevot P., Youngblood D.S., Wu R.P., Iversen P.L., and Lebleu B. Vectorization of morpholino oligomers by the (R-Ahx-R)(4) peptide allows efficient splicing correction in the absence of endosomolytic agents. J. Control. Release 116 (2006) 304-313
3. Abes S., Moulton H., Turner J., Clair P., Richard J.P., Iversen P., Gait M.J., and Lebleu B. Peptide-based delivery of nucleic acids: design, mechanism of uptake and applications to splice-correcting oligonucleotides. Biochem. Soc. Trans. 35 (2007) 53-55
4. Alter J., Lou F., Rabinowitz A., Yin H., Rosenfeld J., Wilton S.D., Partridge T.A., and Lu Q.L. Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathology. Nat. Med. 12 (2006) 175-177
5. Bendifallah N., Rasmussen F.W., Zachar V., Ebbesen P., Nielsen P.E., and Koppelhus U. Evaluation of cell-penetrating peptides (CPPs) as vehicles for intracellular delivery of antisense peptide nucleic acid (PNA). Bioconjugate Chem. 17 (2006) 750-758
6. DeLong R.K., Yoo H., Alahari S.K., Fisher M., Short S.M., Kang S.H., Kole R., Janout V., Regan S.L., and Juliano R.L. Novel cationic amphiphiles as delivery agents for antisense oligonucleotides. Nucl. Acids Res. 27 (1999) 3334-3341
7. El-Andalousi S., Johansson H.J., Lundberg P., and Langel U. Induction of splice correction by cell-penetrating peptide nucleic acids. J. Gene Med. 8 (2006) 1262-1273
8. Fletcher S., Honeyman K., Fall A.M., Harding P.L., Johnsen R.D., and Wilton S.D. Dystrophin expression in the mdx mouse after localised and systemic administration of a morpholino antisense oligonucleotide. J. Gene Med. 8 (2006) 207-216
9. Gebski B.L., Mann C.J., Fletcher S., and Wilton S.D. Morpholino antisense oligonucleotide induced dystrophin exon 23 skipping in mdx mouse muscle. Hum. Mol. Genet. 12 (2003) 1801-1811
10. Kaihatsu K., Huffman K.E., and Corey D.R. Intracellular uptake and inhibition of gene expression by PNAs and PNA-peptide conjugates. Biochemistry 43 (2004) 14340-14347
11. Kang S.H., Cho M.J., and Kole R. Up-regulation of luciferase gene expression with antisense oligonucleotides: implications and applications in functional assay development. Biochemistry 37 (1998) 6235-6239
12. Kole R., Vacek M., and Williams T. Modification of alternative splicing by antisense therapeutics. Oligonucleotides 14 (2004) 65-74
13. Kole R., Williams T., and Cohen L. RNA modulation, repair and remodeling by splice switching oligonucleotides. Acta Biochim. Pol. 51 (2004) 373-378
14. Koppelhus U., Awasthi S.K., Zachar V., Holst H.U., Ebbeson P., and Nielsen P.E. Cell-dependent differential cellular uptake of PNA, peptides and PNA-peptide conjugates. Antisense Nucl. Acid Drug. Dev. 12 (2002) 51-63
15. Lavigne C., and Thierry A.R. Enhanced antisense inhibition of human immunodeficiency virus type 1 in cell cultures by DLS delivery system. Biochem. Biophys. Res. Commun. 237 (1997) 566-571
16. Lavigne C., Yelle J., Sauve G., and Thierry A.R. Lipid-based delivery of combinations of antisense oligodeoxynucleotides for the in vitro inhibition of HIV-1 replication. AAPS PharmSci. 3 (2001) E7
17. Lavigne C., Lunardi-Iskandar Y., Lebleu B., and Thierry A.R. Cationic liposomes/lipids for oligonucleotide delivery: application to the inhibition of tumorigenicity of Kaposi's sarcoma by vascular endothelial growth factor antisense oligodeoxynucleotides. Methods Enzymol. 387 (2004) 189-210
18. Lu Q.L., Rabinowitz A., Chen Y.C., Yokota T., Yin H., Alter J., Jadoon A., Bou-Gharios G., and Partridge T. Systemic delivery of antisense oligoribonucleotide restores dystrophin expression in body-wide skeletal muscles. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 198-203
19. Mercatante D.R., Sazani P., and Kole R. Modification of alternative splicing by antisense oligonucleotides as a potential chemotherapy for cancer and other diseases. Curr. Cancer Drug Targets 1 (2001) 211-230
20. Richard J.P., Melikov K., Vives E., Ramos C., Verbeure B., Gait M.J., Chernomordik L.V., and Lebleu B. Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake. J. Biol. Chem. 278 (2003) 585-590
21. Sazani P., Kang S.H., Maier M.A., Wei C., Dillman J., Summerton J., Manoharan M., and Kole R. Nuclear antisense effects of neutral, anionic and cationic oligonucleotide analogs. Nucl. Acids Res. 29 (2001) 3965-3974
22. Sazani P., Gemignani F., Kang S.H., Maier M.A., Manoharan M., Persmark M., Bortner D., and Kole R. Systemically delivered antisense oligomers upregulate gene expression in mouse tissues. Nat. Biotechnol. 20 (2002) 1228-1233
23. Sazani P., Vacek M.M., and Kole R. Short-term and long-term modulation of gene expression by antisense therapeutics. Curr. Opin. Biotechnol. 13 (2002) 468-472
24. Sazani P., and Kole R. Therapeutic potential of antisense oligonucleotides as modulators of alternative splicing. J. Clin. Invest. 112 (2003) 481-486
25. Schmutz M., Durand D., Debin A., Palvadeau Y., Etienne A., and Thierry A.R. DNA packing in stable lipid complexes designed for gene transfer imitates DNA compaction in bacteriophage. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 12293-12298
26. Shiraishi T., Pankratova S., and Nielsen P.E. Calcium ions effectively enhance the effect of antisense peptide nucleic acids conjugated to cationic Tat and oligoarginine peptides. Chem. Biol. 12 (2005) 923-929
27. Tavitian B., Marzabal S., Boutet V., Kuhnast B., Terrazzino S., Moynier M., Dolle F., Deverre J.R., and Thierry A.R. Characterization of a synthetic anionic vector for oligonucleotide delivery using in vivo whole body dynamic imaging. Pharm. Res. 19 (2002) 367-376
28. Thierry A.R., Rabinovich P., Peng B., Mahan L.C., Bryant J.L., and Gallo R.C. Characterization of liposome-mediated gene delivery: expression, stability and pharmacokinetics of plasmid DNA. Gene Ther. 4 (1997) 226-237
29. Thierry A.R., Vives E., Richard J.-P., Prevot P., Martinand-Mari C., Robbins I., and Lebleu B. Cellular uptake and intracellular fate of antisense. Curr. Opin. Mol. Ther. 5 (2003) 133-138
30. Thierry A.R., Abes S., Resina S., Travo A., Richard J.P., Prevot P., and Lebleu B. Comparison of basic peptides- and lipid-based strategies for the delivery of splice correcting oligonucleotides. Biochim. Biophys. Acta 1758 (2006) 364-374
31. Turner J.J., Ivanova G.D., Verbeure B., Williams D., Arzumanov A.A., Abes S., Lebleu B., and Gait M.J. Cell-penetrating peptide conjugates of peptide nucleic acids (PNA) as inhibitors of HIV-1 Tat-dependent trans-activation in cells. Nucl. Acids Res. 33 (2005) 6837-6849
32. Turner J.J., Arzumanov A.A., and Gait M.J. Synthesis, cellular uptake and HIV-1 Tat-dependent trans-activation inhibition activity of oligonucleotide analogues disulphide-conjugated to cell-penetrating peptides. Nucl. Acids Res. 33 (2005) 27-42
33. Youngblood D.S., Hatlevig S.A., Hassinger J.N., Iversen P.L., and Moulton H.M. Stability of cell-penetrating peptide-morpholino oligomer conjugates in human serum and in cells. Bioconjugate Chem. 18 (2007) 50-60